LabConnect Launches SampleGISTICS® 2.0 to Digitise Clinical Trial Sample
Published: 08 Apr 2026
Author: Towards Healthcare
LabConnect, a global provider of central laboratory services and a functional service provider solution for clinical trials, also launched SampleGISTIC 2.0, an application that enables clinical research sites to scan, record, and transmit participant sample information. The application that enables clinical research sites to scan, record, and transmit participant sample information.
SampleGISTICS 2.0 is designed to eliminate paper-based requisitions, manual data entries, and disconnected courier processes. These persistent challenges can lead to lost samples, delayed shipments, and limited operational oversight.
According to Towards Healthcare, the Clinical trial third-party logistics market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 6.26 billion in 2026 to approximately USD 12.41 billion by 2035, representing a compound annual growth rate (CAGR) of 7.9% from 2026 to 2035. Growth is driven by increasing ongoing and planned clinical trials with rising investment in research and development that enhances operational efficiency, transparency, and reliability in clinical trial logistics. Adoption of advanced therapies and a decentralised clinical trial model requires specialised logistic services to manage stringent temperature control and secure transportation.
About SampleGISTICS 2.0
It provides real-time visibility into sample location, status and stability from collection through laboratory intake. Application-guided workflows in multilingual support, aligned with study protocols, help reduce data entry errors and ensure proper kit usage, supporting downstream shipment and laboratory processes.
This enables fast management of requisitioning, shipment tracking, and sample collection from smartphones or tablets while supporting collection of data and improved compliance with study protocols.
This helps in improving operational transparency and reducing the risk of sample loss and shipment delay.
About LabConnect
LabConnect is a global provider of technology-enabled central laboratory services and functional service provider solutions for pharmaceutical, biotechnology, and contract research organisations. The company connects laboratories, logistics, technology, and scientific expertise through a decentralised laboratory network model to support clinical trials worldwide.
Chief Technology Officer Charles Castano LabConnect said, “SampleGISTICS 2.0 simplifies how sites handle study visit and participant data at the point of collection, securely transferring it into LabConnect’s validated LIMS environment.
A recent report by Towards Healthcare highlights that the Clinical trial third-party logistics market is witnessing the advancement of supply chain technologies, the increasing complexity of design, and the need for specialised outsourced logistic services due to advanced therapies, stringent temperature control, and secure transportation.